| FEV1 %# | PEFAM change¶ | DSS change¶ | β-agonist %# |
Individual measurements taken at treatment weeks 3, 6, 9, and 12 |
Within-patient | 13.7 | 22.8 | 0.44 | 33.4 |
Between-patient | 14.3 | 38.2 | 0.70 | 43.4 |
Average of 2 measurements taken at treatment weeks 3+6 and 9+12 |
Within-patient | 10.8 | 19.5 | 0.37 | 26.3 |
Between-patient | 13.9 | 37.4 | 0.68 | 42.9 |
Estimated variabilities for average of 3 measurements+ |
Within-patient | 9.0 | 16.1 | 0.31 | 22.3 |
Between-patient | 14.3 | 38.2 | 0.70 | 43.4 |